| pubmed-article:11535726 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C0005834 | lld:lifeskim |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C1704656 | lld:lifeskim |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C0332152 | lld:lifeskim |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C0439801 | lld:lifeskim |
| pubmed-article:11535726 | lifeskim:mentions | umls-concept:C0085101 | lld:lifeskim |
| pubmed-article:11535726 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11535726 | pubmed:dateCreated | 2001-9-5 | lld:pubmed |
| pubmed-article:11535726 | pubmed:abstractText | 186Re-labeled chimeric monoclonal antibody U36 (cMAb U36) was recently evaluated in a phase I dose escalation study in head and neck cancer patients. All 13 patients received 99mTc-labeled cMAb U36 before 186Re-cMAb U36 radioimmunotherapy. The aim of this study was to evaluate the suitability of multiple or limited blood sampling to predict clearance, red marrow absorbed dose, and myelotoxicity of 186Re-cMAb U36. | lld:pubmed |
| pubmed-article:11535726 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11535726 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11535726 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11535726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11535726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11535726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11535726 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11535726 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11535726 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11535726 | pubmed:issn | 0161-5505 | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:RoosJ CJC | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:SnowG BGB | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:QuakJ JJJ | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:van DongenG... | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:CloosJJ | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:de BreeRR | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:WilhelmA JAJ | lld:pubmed |
| pubmed-article:11535726 | pubmed:author | pubmed-author:ColnotD RDR | lld:pubmed |
| pubmed-article:11535726 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11535726 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:11535726 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11535726 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11535726 | pubmed:pagination | 1364-7 | lld:pubmed |
| pubmed-article:11535726 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:meshHeading | pubmed-meshheading:11535726... | lld:pubmed |
| pubmed-article:11535726 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11535726 | pubmed:articleTitle | Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapy. | lld:pubmed |
| pubmed-article:11535726 | pubmed:affiliation | Department of Otolaryngology/Head and Neck Surgery, Vrije Universiteit Medical Center, Amsterdam, The Netherlands. | lld:pubmed |
| pubmed-article:11535726 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11535726 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11535726 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11535726 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11535726 | lld:pubmed |
